✦ LIBER ✦

ChemInform Abstract: Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

✍ Scribed by Mark Whittaker; Christopher D. Floyd; Peter Brown; Andrew J. H. Gearing

Publisher: John Wiley and Sons
Year: 2010
Weight: 26 KB
Volume: 30
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.199948316

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Piperazine-Based Matrix Metalloproteinase Inhibitors.

✍ Biswanath De; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Carboxylate Inhibitors for Matrix Metalloproteinases.

✍ Tetsunori Fujisawa; Shin-ichi Katakura; Shinjiro Odake; Yasuo Morita; Junko Yasu 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Thiol Containing Inhibitors of Matrix Metalloproteinases.

✍ Cynthia A. Fink; J. Eric Carlson; Charles Boehm; Patricia McTaggart; Ying Qiao; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

ChemInform Abstract: Emerging Therapeuti

ChemInform Abstract: Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase Inhibitors

✍ A. D. WHITE; T. M. A. BOCAN; P. A. BOXER; J. T. PETERSON; D. SCHRIER 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 1 views

ChemInform Abstract: Asymmetric Synthesi

ChemInform Abstract: Asymmetric Synthesis of Mercaptoalcohols — Matrix Metalloproteinase Inhibitors.

✍ K. Paulvannan; Tao Chen 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

ChemInform Abstract: Discovery of Potent

ChemInform Abstract: Discovery of Potent, Achiral Matrix Metalloproteinase Inhibitors.

✍ S. PIKUL; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

Discovery of Potent, Achiral Matrix Metalloproteinase Inhibitors. -A novel series of matrix metalloproteinase inhibitors such as (I) based on 1,3-piperazine is synthesized and evaluated for the inhibition of callagenase-1, stromelysin, matrilysin, and gelatinase-B. The most active compound is (Ib).